(Q42708700)
Statements
1 reference
Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors (English)
1 reference
Jose Baselga
1 reference
Geoffrey I Shapiro
1 reference
Jordi Rodon
1 reference
Cynthia Bedell
1 reference
Eunice L Kwak
1 reference
Irene Braña
1 reference
Shuchi S Pandya
1 reference
Christian Scheffold
1 reference
A Douglas Laird
1 reference
Linh T Nguyen
1 reference
Yi Xu
1 reference
Coumaran Egile
1 reference
Gerald Edelman
1 reference
28 October 2013
1 reference
1 reference
20
1 reference
1
1 reference
233-245
1 reference
Identifiers
1 reference
1 reference